Press release
Crucell N.V. (NL) - Crucell Secures EUR 2 Million Grant from Dutch Ministry of Economic Affairs to Discover Antibodies Against Antibiotic-resistant Bacterial Infections
Crucell Secures EUR 2 Million Grant from Dutch Ministry of Economic Affairs to Discover Antibodies Against Antibiotic-resistant Bacterial InfectionsLeiden, The Netherlands, September 16, 2005 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has received a grant of up to EUR 2 Million from the SenterNovem Innovation Subsidy for Collaborative Projects program of the Dutch Ministry of Economic Affairs. The grant supports a collaborative effort aimed at applying Crucell´s MAbstract® technology to the discovery of antibodies to assist in the future development of new medicines against antibiotic-resistant bacteria.
Antibiotic resistance is spreading at an alarming rate among bacteria, with more than 200,000 patients dying of hospital-acquired infections annually in the US and Europe. Bloodstream infections, pneumonia and tissue infections affect almost 2 million patients each year, contributing US$ 5 billion to annual healthcare costs in the US alone.
Crucell has assembled a network of leading research institutes for the project, including Harvard Medical School in the US and specialized groups from Dutch universities. In the course of the project the Company intends to exploit its antibody technology, known as MAbstract®, together with its vaccine and production platforms, to facilitate the future development of treatments against antibiotic-resistant bacteria. MAbstract® technology can be used to discover drug targets, such as proteins from infectious agents including bacteria and viruses, and also to identify human antibodies against those drug targets.
"Our experience and knowledge of our core technologies continues to grow as we forge ahead with our vaccine and antibody development programs," said Dr Jaap Goudsmit, Crucell´s Chief Scientific Officer. "We are proud that we can now apply this expertise to the field of drug-resistant bacterial diseases that is such a prominent problem in hospital settings."
About SenterNovem
SenterNovem is an agency of the Dutch Ministry of Economic Affairs. Its stimulation programs and different subsidy schemes target high technology, energy, the environment, exports and international collaboration.
About Crucell
Crucell N.V. is a biotechnology company focused on developing vaccines and antibodies that prevent and treat infectious diseases, including Ebola, influenza, malaria, West Nile virus and rabies. The company´s development programs include collaborations with: sanofi pasteur for influenza vaccines; the U.S. National Institutes of Health for Ebola and malaria vaccines; and GlaxoSmithKline (GSK), Walter Reed Army Institute of Research and New York University for a malaria vaccine. Crucell´s products are based on its PER.C6® production technology. The company also licenses its PER.C6® technology to the biopharmaceutical industry. Licensees and partners include DSM Biologics, GSK, Centocor/J&J and Merck & Co., Inc. Crucell is headquartered in Leiden, The Netherlands, and is listed on the Euronext and NASDAQ stock exchanges (ticker symbol CRXL). For more information, please visit www.crucell.com.
This press release contains forward-looking statements that involve inherent risks and uncertainties. We have identified certain important factors that may cause actual results to differ materially from those contained in such forward-looking statements. For information relating to these factors please refer to our Form 20-F, as filed with the U.S. Securities and Exchange Commission on April 14, 2005, and the section entitled "Risk Factors". The company prepares its financial statements under generally accepted accounting principles in the United States (US GAAP).
Click here for a PDF version of this press release:
PDF version
For further information please contact:
Crucell N.V.
Harry Suykerbuyk
Director Investor Relations and Corporate Communications
Tel. +31 (0)71 524 8718
h.suykerbuyk@crucell.com
For Crucell in the US:
Redington, Inc.
Thomas Redington
Tel. +1 212-926-1733
tredington@redingtoninc.com
The issuer is solely responsible for the content of this announcement.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Crucell N.V. (NL) - Crucell Secures EUR 2 Million Grant from Dutch Ministry of Economic Affairs to Discover Antibodies Against Antibiotic-resistant Bacterial Infections here
News-ID: 136 • Views: …
More Releases from Crucell N.V.
direct/ Crucell N.V. (NL) - CRUCELL AND BERNA BIOTECH: TOGETHER CREATING THE LE …
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
This announcement and related materials do not constitute an offer for Berna shares. An offer is expected to be made in due course as set out in this press release.
Furthermore, this press release is not a pre-announcement within the meaning of Swiss takeover laws, is not binding and…
Crucell N.V. (NL) - Crucell and DSM Announce PER.C6® Licensing Agreement with …
Crucell and DSM Announce PER.C6® Licensing Agreement with IQ Corporation for Production of Monoclonal Antibodies against Anthrax
Leiden/Sittard, The Netherlands, October 19, 2005 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) and allied contract manufacturer DSM Biologics announced today that they have signed a PER.C6® research license agreement with Dutch biotechnology company IQ Corporation. This license agreement allows IQ to evaluate and use the PER.C6® cell line for production…
Crucell N.V. (NL) - Crucell Announces Third Quarter 2005 Results
Crucell Announces Third Quarter 2005 Results
- Strong increase in quarter and year-to-date revenues.
- New development programs in rabies and tuberculosis.
- Further AdVac®-based vaccine technology development contracts with US partners.
- Initiated therapeutic protein programs.
Leiden, The Netherlands, October 17, 2005 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) today announced its financial results for the third quarter and for the nine months ended September 30, 2005.
Revenue…
Crucell N.V. (NL) - Crucell Updates Progress in Scale-up of Cell-culture-based I …
Crucell Updates Progress in Scale-up of Cell-culture-based Influenza Vaccine Programs
Leiden, The Netherlands, October 13, 2005 - Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has received a milestone payment of EUR 1 million (US$ 1.2 million) from sanofi pasteur, the vaccines business of the sanofi-aventis group, in acknowledgement of the progress the company has made in development of novel influenza products using Crucell´s proprietary PER.C6® cell line technology. The…
More Releases for Dutch
Dutch Mendenhall to Moderate Athletes in Business Panel
Las Vegas, NV - July 9, 2024 - Dutch Mendenhall [https://www.linkedin.com/in/dutchmendenhall], the esteemed owner of Wentworth Golf Club [https://wentworthgolfclub.org/], best-selling author of Money Shackles, and former Division 1 volunteer coach, will moderate the "Athletes in Business" panel at The Palms Las Vegas on Sunday, July 14, 2024. This event will bring together some of the most influential athletes turned business professionals to share their insights and experiences.
Dutch Mendenhall's diverse background…
Dutch Mendenhall Named "Entrepreneur to Watch in 2024"
Los Angeles, CA - July 8, 2024 - Author, investor, and educator Dutch Mendenhall [https://dutchmendenhall.com/] has been honored as an "Entrepreneur to Watch in 2024" by the California Business Journal [https://calbizjournal-com.cdn.ampproject.org/v/s/calbizjournal.com/an-intriguing-collection-of-entrepreneurs-to-watch-in-2024/amp/?amp_gsa=1&_js_v=a9&usqp=mq331AQIUAKwASCAAgM%3D#amp_ct=1720197367143&_tf=From%20%251%24s&aoh=17201973604043&csi=1&referrer=https%3A%2F%2Fwww.google.com&share=https%3A%2F%2Fcalbizjournal.com%2Fan-intriguing-collection-of-entrepreneurs-to-watch-in-2024%2F]. This prestigious recognition highlights Mendenhall's remarkable contributions to innovation, visionary leadership, and adaptability, which have enabled his ventures to flourish despite economic challenges and technological advancements.
California Business Journal's selection process emphasized a commitment to groundbreaking ideas, a transformative vision…
Aromatic Solvents Market 2018 Leading Players :- Celanese Corporation , Royal Du …
The Global Aromatic Solvents Market report includes Aromatic Solvents Market Revenue, Investment Opportunity, Market Features, Market Demand by Segment & Aromatic Solvents Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Aromatic Solvents Price during the Forecast
Aromatic Solvents Market Scenario:
The lithography Aromatic Solvents process segment is anticipated to observe a higher CAGR during the forecast…
Dutch Watch Professionals (DWP) organizes a bourse for Dutch watch brands
Utrecht, The Netherlands – The Dutch Watch Professionals (DWP), founded at the beginning of 2017, intends to become a branche organization for Dutch watch brands and the deliverers of this industrial branche. On May 27 2017 they organize the first Dutch Watch Showcase (DWS), a bourse for the above mentioned companies, taking place in Utrecht, The Netherlands.
In 2016 a couple of Dutch watch brands came up with the idea to…
Guyson Appoint New Dutch Distributor
Leading industrial finishing equipment manufacturer Guyson International is pleased to announce the appointment of Blasteq, as Guyson’s new finishing equipment distributor for the Netherlands.
Blasteq already have several years’ experience of selling soda blasting equipment and its blast media in and around the Netherlands from their base in Lisse, so they are well placed to represent Guyson’s range of manual bead blast cabinets and ultrasonic cleaning equipment to the Dutch industrial…
Maritime Dutch pictures online for sale
HILVERSUM – One of the largest Dutch maritime archives can be downloaded directly online. If you immediately require professional shipping, water sports or maritime heritage pictures look no further but check out on dutchshippingarchive dot nl The pictures of the largest inland shipping fleet and the maritime largest heritage fleet in the world are now available in high resolution, directly after payment. Also for a picture to hang on…